President Donald Trump said on Friday the U.S. Food and Drug Administration (FDA) had granted authorization to Gilead Sciences Inc (GILD.O) for emergency use of its experimental antiviral drug Remdesivir to treat patients with COVID-19.
During a meeting in the Oval Office with the president, Gilead Chief Executive Daniel O’Day called the move an important first step and said the company was donating 1 million vials of the drug to help patients.
According to Amer Bahbouha, professor of geography and specialist in meteorology, we will quickly have…
The members of the Security Council expressed their deep concern over reports of the discovery…
The police force this evening burst into the headquarters of the Maison de l'Avocat as…
The public prosecutor's office at the Sousse Court of First Instance has issued Arrest Warrants…
According to Mosaïque FM's sources, journalists Borhène Bsaïes and Mourad Zeghidi are currently being interrogated…
The arrest warrant issued against Sonia Dahmani was executed a short time ago and, according…
This website uses cookies.